FitLife Brands, Inc. (FTLF) - 10-K Summary
Business Context and Reporting Period
Company: FitLife Brands, Inc.
Reporting Period: Fiscal Year Ended December 31, 2025
Business Overview: FitLife Brands is a provider of nutritional supplements and wellness products operating under multiple brand portfolios including NDS Nutrition, iSatori, MRC, MusclePharm, and Irwin Naturals. The company distributes products through wholesale channels (notably GNC, CVS, Walmart) and direct-to-consumer e-commerce platforms (primarily Amazon).
Key Event: On August 8, 2025, the Company acquired substantially all assets of Irwin Naturals for $42.5 million, significantly expanding its product portfolio and wholesale presence.
Key Financial Metrics
| Metric (in thousands) | 2025 | 2024 |
|---|---|---|
| Revenue | $81,458 | $64,469 |
| Gross Profit | $31,453 | $28,080 |
| Gross Margin | 38.6% | 43.6% |
| Operating Income | $10,062 | $13,119 |
| Net Income | $6,326 | $8,984 |
| Diluted EPS | $0.63 | $0.91 |
| Operating Cash Flow | $7,439 | $9,610 |
| Total Debt (Principal) | $44,702 | $13,125 |
| Cash & Equivalents | $1,646 | $4,468 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 26% to $81.5 million, driven primarily by the inclusion of Irwin Naturals revenue ($19.5 million) post-acquisition. Legacy FitLife revenue declined 4% year-over-year.
- Margin Compression: Gross margin decreased 500 basis points to 38.6%. This was attributed to Irwin's historically lower margins and $1.045 million in inventory step-up amortization. Excluding the step-up, margin would have been 39.9%.
- Profitability Decline: Net income decreased 30% to $6.3 million. Despite higher revenue, profitability was impacted by a 714% increase in merger and acquisition expenses ($2.1 million) and a 41% increase in SG&A expenses due to the integration of Irwin.
- Debt Expansion: Total debt increased significantly to approximately $44.7 million to fund the Irwin acquisition, replacing previous term loans with a new $40.6 million term loan and utilizing a $10 million revolving line of credit.
Guidance, Outlook, and Risks
Management Commentary: Management views the Irwin acquisition as a strategic move to diversify product offerings and strengthen wholesale channels. The company expects GNC sales to decrease as a percentage of total revenue due to the addition of Irwin's mass-market wholesale sales. The company is actively integrating Irwin's online sales channels, which were minimal prior to acquisition.
Risks and Contingencies:
- Customer Concentration: Amazon accounted for approximately 49% of total sales in 2025. GNC accounted for 14% of sales (down from 23% in 2024). Loss of access to these platforms would be material.
- Debt Covenants: The new credit agreement requires maintaining a Senior Funded Debt to EBITDA ratio of no more than 2.75:1.00 through mid-2026, tightening to 2.50:1.00 thereafter.
- Regulatory Environment: The company faces ongoing regulatory scrutiny from the FDA and FTC regarding product claims, labeling, and ingredients.
- Supply Chain: Reliance on third-party contract manufacturers for all production creates risks regarding quality control and supply continuity.
Investor Verification Checklist
- Irwin Integration: Verify the success of integrating Irwin's wholesale and online channels and whether projected synergies are being realized.
- Amazon Dependency: Monitor the 49% revenue concentration on Amazon and any changes in platform fees or seller policies.
- Debt Service: Assess the company's ability to meet the new debt covenants (Debt/EBITDA & Fixed Charge Coverage) given the increased leverage.
- Legacy Performance: Analyze the 4% decline in Legacy FitLife revenue to determine if it is a temporary trend or indicative of broader market headwinds.
- Inventory Valuation: Review the $1.045 million inventory step-up amortization and the $247,000 allowance for obsolete inventory to ensure accurate cost of goods sold reporting.